Related Experiment Video
Updated: Sep 9, 2025

08:45
Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
13.9K
Antifungal Drug Resistance.
1School of Biosciences, University of Birmingham, Birmingham, UK. j.rhodes@bham.ac.uk.
Current Topics in Microbiology and Immunology
|September 4, 2025
Summary
Antifungal resistance is a growing global crisis, exacerbated by climate change and emerging fungal pathogens. Addressing this requires integrated surveillance, global collaboration, and a unified approach between medical and plant mycologists.
Area of Science:
- Mycology
- Antimicrobial Resistance
- Public Health
Background:
- Fungal infections represent a significant threat to public health and food security worldwide.
- Rising antifungal drug and fungicide resistance, coupled with climate change, is escalating this threat.
- Emerging pathogenic fungi and shifting at-risk populations compound the global crisis.
Purpose of the Study:
- To review the primary mechanisms driving antifungal drug and fungicide resistance.
- To explore novel antifungal drugs and their modes of action.
- To identify future strategies for risk reduction in antifungal resistance.
Main Methods:
- Literature review of antifungal resistance mechanisms.
- Analysis of emerging antifungal drug classes and their applications.
- Synthesis of One Health principles and surveillance strategies.
Main Results:
- Identified key mechanisms of antifungal and fungicide resistance.
- Highlighted novel drug classes and their potential impact.
- Emphasized the critical need for integrated One Health approaches and surveillance.
Conclusions:
- Integrating One Health and robust surveillance is essential for managing antifungal resistance.
- Global collaboration among diverse stakeholders is crucial to combat rising resistance trends.
- A unified antifungal stewardship plan, developed through collaboration between medical and plant mycologists, is vital.
Related Concept Videos
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Development of Antibiotic Resistance
197
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
197
Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156

